This October 5–8 in San Diego, The MedTech Conference’s CEOs Unplugged series unites top medtech executives for unfiltered discussions that cut through the noise and deliver exclusive insights into what’s next for our industry.
New sessions have just been added, tackling the most pressing issues including the impact of AI on novel devices, monetizing data insights, and an overview of the M&A landscape in medtech.
Critical Insights, Innovation, & Industry Trends
1. Key Perspectives on MedTech M&A Trends
- Sheryl Jacobson, Global MedTech Leader, Deloitte
- Brian Blaser, CEO, QuidelOrtho
- Brian Miller, Co-Founder and Managing Partner, Linden Capital
- Hemanth Reddy, Chief Strategy Officer, Resmed
Sponsored by Deloitte
2. The Powerful Convergence of Two Global Revolutions
- Martin Magazzolo, Chief Revenue Officer, Honeywell Life Sciences
- Jeff DiLullo, Chief Region Leader, Philips North America
- Tracy MacNeal, President & CEO, Materna Medical
- Julien Sauvagnargues, Exec. Vice Pres., Regional Representative Officer, President and CEO, Americas, Olympus Corporation of the Americas
Sponsored by Honeywell Life Sciences
3. The Digital Dilemma: When Data Becomes the Product
- Myla Maloney, Chief Growth Officer, Premier
- Robert Albert, Chief Executive Officer, B. Braun of America
- Christopher Barry, EVP, Group President, Medical Solutions, Solventum
- Carsten Schroeder, President & CEO, Terumo Neuro
Sponsored by Premier
- Keith Pagnani, Co-Head of Mergers & Acquisitions, North America, Sullivan & Cromwell
- Kevin Lobo, Chief Executive Officer, Stryker
- Katie Ossman, Partner, Water Street Healthcare Partners
- Tim Schmid, Executive Vice President and Worldwide Chairman, Johnson & Johnson MedTech
Sponsored by Sullivan & Cromwell
Explore the #MedTechCon program to see the CEOs, innovators, and policymakers discussing the trends, breakthroughs, and challenges transforming health care—don’t miss your chance to be part of the conversation.